Study Enrollment

Your details will not be published or shared.

Clinical Trial

EA1131 A Randomized Phase III Post Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy

The main purpose of this study is to compare getting more treatment with capecitabine (i.e. one of the usual approaches), to any good and bad effects of getting more treatment with a platinum-based chemotherapy (cisplatin or carboplatin), after surgery.

Eligibility Criteria

  • 18 years old Must have confirmed Triple Negative Breast Cancer ECOG performance of 0 or 1

Contact Information

    Sharad Ghamande, MD

    (706) 721-3992